哈尔滨医科大学八十周年校庆系列学术活动(2)

MEMBERSHIP OF ACADEMIC ASSOCIATION: Member of American Society of Nephrology (ASN); Member of International Society of Nephrology (ISN); Member of American Physiological Society (APS) Member of Chinese Society of Physiology (CSP) Member of American Diabetes Association (ADA)

Member of American Association for the Advancement of Science (AAAS)

AWARD AND HONOR POSITION:

National Guang Hua Price, 1993, Beijing Medical University

Guest Associate Professor, 1998,05-2001,05, Department of Physiology, Beijing University Medical Center (Beijing Medical University), Beijing100081;

Guest Professor, 2002, 1- present, Division of Nephrology, The General Hospital of PLA, Beijing 100021

ACADEMIC POSITION: Co-Chair, the Symposium “Novel Renal Pathways for Prevention of Diabetes and Obesity-Related Renal and Vascular Disease”. The 2005 Annual Meeting of the ASN, Nov 8-13, Philadelphia, Pennsylvania.

Chairman, the Eicosanoid Receptors Symposium, the International Eicosanoids Conference, Beijing, July 05, 2005

Reviewer, Study Section of Physiology, Pathophysiology and Internal Medicine, National Nature Science Foundation of China (NNSFC), 2004-2008

Reviewer, Study Section of Immunology, National Nature Science Foundation of China (NNSFC), 2005;

Review Committee member, NIDDK RFA-DK-04-012, Study Section of “PKD Research and Translation Core Centers”;

Review Committee member, NIDDK RFA-DK-05-001, Study Section of “Preventing Mitochondrial Oxidative Stress in Diabetes and Obesity”;

Chairman, The Cross-Section Symposium “\2003 FASEB meeting, April 11-14, San Diego.

Chair, The first Diabetes Symposium at Beijing University Medical Center, December 20, 2003;

INVITED REVIEWS: 1. Breyer MD, Zhang Y, Guan Y, Hao CM, Hebert RL, Breyer RM. Regulation of renal

function by prostaglandin E receptors. Kidney Int. 1998; 54 (suppl. 67):S88-S94

2. Guan Y and Breyer MD. Peroxisome proliferator-activated receptors (PPARs): Novel

therapeutic targets in renal disease. Kidney Int. 2001; 60 (1):14-30.

3. Guan Y, Zhang Y and Breyer MD: The role of PPARs in the transcriptional control of

cellular processes. Drug News & Perspective 2002; 15(3):147-154.

4. Guan Y: Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic

targets for prevention of diabetes, dyslipidemia, hypertension and obesity. Minerva Urologica e Nefrologica 2002; 54:65-79

5. Guan Y: PPAR system and its relationship to renal complications of the metabolic

syndrome. J. Am. Soc. Nephrol. (invited review) 2004 Nov;15(11):2801-15.

6. Guan Y: PPAR-gamma agonists and diabetic nephropathy. Current Diabetes Reports

(in presss) (Invited Review).

BOOK CHAPTERS 1. Targeted gene disruption of the prostaglandin E2 EP2 receptor. In Eicosanoids and

Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury. Edited by Honn et al., pp321-326, Kluwer Academic/Plenum Publishers, 2002

2. Vasoactive substances and kidney. in Nephrology . Edited by Haiyan Wang. 2nd ed.

pp 84-180, Public Health Publish House. Beijing. China. 1996

3. Endocrinological Function of Kidney. In Modern Nephrology. Edited by Jije Jiang. 1st

ed. Military Medicine Publish House (in press)

4. Peroxisome proliferator-activated receptors (PPARs) and cardiovascular disease. In

Practical Cardiovascular Receptorology. Edited by Daowen Wang. 1st ed. Science Press, Beijing, ISBN 7-03-009284-8/R.687, 2001, P50-61

5. Scavenger Receptors and cardiovascular disease. In Practical Cardiovascular

Receptorology. Edited by Daowen Wang. 1st ed. Science Press, Beijing, ISBN 7-03-009284-8/R.687, 2001, p62-70

LIST OF PUBLICATIONS 1. Yiang B and Guan Y: Chronic renal failure and recombinant human erythropoietin.

Chinese Journal of Nephrology. 1990. 6:388-391.

2. Guan Y and Qian T: Fibronectin and renal diseases. Advances in Internal Medicine. 1991. 18(5):221-224.

3. Guan Y and Xiu K: Role of reactive oxygen species in gastrointestinal ischemic injury.

Jiangsu Medical Journal 1991. 17(6):322-324.

4. Guan Y, Qian T, and Jiang J: Alteration of the plasma fibronectin concentration in

various kidney disease. Chinese Journal of Nephrology. 1991. 7:81-84.

5. Guan Y, Zhao X, and Jiang J: Significance of hypercoagulable indexes in lupus

nephritis. Tianjin Medical Journal. 1991. 19(6): 349-351.

6. Guan Y, Jiang J, and Qian T: Effect of oral supply of essential amino acids on the

function of kidney and Fc receptor of the peritoneal macrophages in rats with chronic renal failure. Jiangsu Medical Journal. 1991. 17(1):10-12.

7. Zhang, Y, Guan Y, and Jiang J: Structural and functional changes in aged kidneys.

Jiangsu Medical Journal. 1992. 18(1):32-33.

8. Guan Y and Jiang J: Clinical application of recombinant human erythropoietin

(rhuEPO). J. Nephrol. Dialy. Transplant. 1993. 2(1):3-6.

9. Guan Y, Jiang J, Sen Y: Polypeptide growth factors. Advances in Nephrology and Urology. 1993. 13(3):99-103.

10. Guan Y, Wang H: Application of polymerase chain reaction (PCR) technique in

nephrology. Advances in Nephrology and Urology. 1993. 13(4): 162-1655.

11. Guan Y, Jiang J, Qian T: Cyclosporine-associated hypertension. Advances in Internal Medicine. 1993. 20(2):71-73.

12. Guan Y. Decreased expression of c-fos and c-jun oncogenes in aged rat kidneys. Oral

presentation at the First Chinese National Congress of hypertension, fluid, electrolyte metabolism. Apr. 19-21, 1993. Shanghai. China.

13. Guan Y, Xio D and Jiang J: Effect of short-term non-insulin therapy on serum lipid

levels in NIDDM patients. Acta Academia Medicinae Nantong. 1993. 12 …… 此处隐藏：8755字，全部文档内容请下载后查看。喜欢就下载吧 ……